Endobronchial Ultrasound Biopsy Market Analysis & Forecast: 2025-2032

Endobronchial Ultrasound Biopsy Market Size and Forecast – 2026 – 2033

The Global Endobronchial Ultrasound Biopsy Market size is estimated to be valued at USD 1.48 billion in 2026 and is expected to reach USD 3.12 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 11.4% from 2026 to 2033.

Global Endobronchial Ultrasound Biopsy Market Overview

Endobronchial ultrasound biopsy products consist of imaging and biopsy systems used to visualize and sample tissues within the lungs and surrounding lymph nodes. These systems combine bronchoscopy with ultrasound imaging to guide fine-needle aspiration procedures. The products enable minimally invasive diagnosis of lung cancer, infections, and mediastinal diseases. Key features include high-resolution imaging, precise needle guidance, and improved diagnostic accuracy.

Key Takeaways

• Convex Probe EBUS dominates the product segment by holding over 53% of the market share, driven by superior visualization and biopsy capabilities. Linear Probe EBUS is the fastest growing, favored for its versatility in complex navigation.

• Lung Cancer Diagnosis remains the prime application area, commanding the largest industry share owing to increasing lung cancer prevalence and stringent screening programs globally. Tuberculosis diagnosis application is expanding in emerging markets due to rising respiratory illness burden.

• North America dominates the regional market with over 35% industry share, supported by extensive healthcare infrastructure and adoption of cutting-edge medical devices. Asia Pacific registers the highest CAGR, propelled by improved healthcare funding and surging demand for advanced diagnostics in populous countries like China and India.

• The growing emphasis on value-based healthcare and procedural accuracy is likely to sustain robust market growth and increased business opportunities for market companies.

Endobronchial Ultrasound Biopsy Market Segmentation Analysis

To learn more about this report, Download Free Sample

Endobronchial Ultrasound Biopsy Market Insights, By Product Type

Convex Probe EBUS dominates the market share. The Convex Probe EBUS segment leads due to its superior visualization capabilities during biopsy procedures, enabling physicians to accurately assess lymph nodes and peripheral lesions. This segment’s technological superiority and wide adoption in clinical diagnostics across regions such as North America and Europe have cemented its dominance. Linear Probe EBUS is the fastest-growing segment, credited with enhanced maneuverability and suitability for complex anatomical navigation, making it increasingly favored in Asia-Pacific countries.

Endobronchial Ultrasound Biopsy Market Insights, By Application

Lung Cancer Diagnosis commands the largest share due to the global rise in lung cancer incidence and intensified screening protocols. This segment benefits from growing screening programs and clinical reliance on EBUS to achieve minimally invasive biopsies. Sarcoidosis Detection is an emerging application area, with increasing diagnostic confidence reported in 2026 clinical studies advocating EBUS use for granulomatous lung disease. Tuberculosis Diagnosis is gaining traction primarily in emerging economies, where EBUS facilitates early and accurate detection, critical to disease management.

Endobronchial Ultrasound Biopsy Market Insights, By End-User

Hospitals dominate market revenue, leveraging comprehensive infrastructure and skilled personnel to deploy advanced EBUS systems. This segment benefits from steady procedure volumes and investments in pulmonology services. Ambulatory Surgical Centers represent the fastest-growing end-user segment, attributed to rising outpatient procedure adoption and the development of portable EBUS devices suitable for ASC environments. Diagnostic Centers and Research Institutes maintain specialized roles, focusing on targeted diagnostic and investigational protocols, respectively.

Endobronchial Ultrasound Biopsy Market Trends

• The Endobronchial Ultrasound Biopsy market trend underscores a rapid shift toward AI-enhanced procedural systems that deliver improved diagnostic accuracy and reduced operator dependency.

• Advances in real-time imaging combined with predictive analytics enable earlier disease detection, demonstrated by studies in 2026 showcasing a 12% accuracy improvement with AI integration.

• Additionally, the evolution of compact EBUS devices designed for ambulatory surgical centers is creating novel market opportunities by addressing outpatient procedure requirements, witnessed by a 10% increase in ambulatory procedures in Europe in 2026.

• Regional dynamics reveal North America as the dominating region owing to exceptional healthcare infrastructure, reimbursement frameworks, and the presence of leading market companies like Olympus and Siemens Healthineers.

• North America holds a commanding 35% market share with sustained investment in respiratory diagnostics.

• Meanwhile, Asia Pacific is the fastest-growing region, exhibiting a CAGR of approximately 13%, fueled by rapid healthcare modernization, growing government initiatives in pulmonary care, and increased demand in China and India.

Endobronchial Ultrasound Biopsy Market Insights, By Geography

To learn more about this report, Download Free Sample

North America Endobronchial Ultrasound Biopsy Market Analysis and Trends

In North America, the dominance in the Endobronchial Ultrasound Biopsy market is driven by high adoption of technologically advanced devices and expansive hospital infrastructure. Major players such as Medtronic and Boston Scientific have contributed to over 40% of regional market revenue by focusing on clinical partnerships and customized product development aligned with regulatory requirements. Additionally, the U.S. saw a 14% increase in diagnostic pulmonology procedures involving EBUS in 2026, supported by reimbursement improvements.

Asia Pacific Endobronchial Ultrasound Biopsy Market Analysis and Trends

Meanwhile, Asia Pacific exhibits the fastest growth trend fueled by expanding healthcare access and infrastructure development. Government-led screening programs in China and India have increased early lung disease detection efforts, with 18% procedure growth reported in 2026 alone. Regional players such as Fujifilm and Mindray have enhanced market revenue by developing cost-effective EBUS solutions tailored to local clinical needs.

Endobronchial Ultrasound Biopsy Market Outlook for Key Countries

USA Endobronchial Ultrasound Biopsy Market Analysis and Trends

The USA market remains the largest contributor worldwide, driven by aggressive investments in healthcare technologies and an increasing focus on early lung cancer diagnosis. Leading companies have established strong footholds through product launches like Olympus’s latest linear probe EBUS evices, resulting in a 9% market share increase in 2026. Additionally, the high reimbursement landscape and rigor in clinical trials promote rapid integration of cutting-edge EBUS technologies across major healthcare institutions.

China Endobronchial Ultrasound Biopsy Market Analysis and Trends

China's market is rapidly evolving due to governmental prioritization of respiratory healthcare and increasing incidence of pulmonary disorders. Domestic manufacturers such as Mindray are actively collaborating with international partners to introduce innovative EBUS biopsy devices. These efforts, coupled with strategic government funding exceeding USD 50 million annually for lung disease diagnostics, have resulted in a 17% growth rate of EBUS procedures in urban healthcare centers recorded in 2026.

Analyst Opinion

• Rising demand for real-time minimally invasive diagnostic solutions is a crucial driver propelling the EBUS market revenue, with procedural volumes increasing annually by over 12% in North American hospitals in 2026. This reflects a shift in clinical protocols favoring precision and reduced patient recovery time.

• Cost optimization through innovative EBUS system designs has improved market share in emerging economies, as evident from a 9% expansion in procedure adoption in India and Southeast Asia in the first half of 2026, indicating strong growth potential in demand-side indicators.

• Pricing trends in the EBUS device segment reveal a gradual reduction in unit costs, facilitating broader accessibility; the global average price per EBUS system dropped approximately 5% between 2023 and 2026, aligned with growing manufacturing capacity and technological advances.

• Import-export metrics indicate robust cross-border trade in key components such as ultrasound probes, with Asia-Pacific countries accounting for 27% of global exports of medical ultrasound equipment in 2023, supporting supply chain expansion and market dynamics globally.

Market Scope

Endobronchial Ultrasound Biopsy Market Growth Factors

Key growth drivers underpinning the Endobronchial Ultrasound Biopsy market expansion incorporate the rising prevalence of lung cancer and associated early diagnosis protocols, improving the adoption of EBUS technology. Regulatory approvals of novel EBUS devices with enhanced imaging resolution have accelerated product launches globally, as seen in multiple FDA clearances in 2026. Technological advancements, including integrated navigation systems with artificial intelligence support, have boosted diagnostic accuracy, broadening clinical applications beyond oncology to sarcoidosis and tuberculosis diagnosis. Additionally, increasing expenditure on pulmonary healthcare infrastructure in emerging markets has augmented market demand, highlighted by government funding initiatives in developing countries like India, which increased by over 15% in pulmonary diagnostic capabilities in 2026.

Endobronchial Ultrasound Biopsy Market Development

In 2023, Olympus introduced the BF-UC190F EBUS bronchoscope, featuring enhanced distal tip angulation of up to 160° and a reduced outer diameter of approximately 6.6 mm. These design improvements enable pulmonologists to access hard-to-reach lymph nodes more effectively during endobronchial ultrasound (EBUS) procedures. The system is complemented by Olympus’ ViziShot EBUS-TBNA needles, which are designed to improve sampling accuracy, procedural efficiency, and diagnostic confidence in lung cancer staging and mediastinal assessment.

In 2024, Broncus Medical launched the BioStar TBNA Needle, a next-generation transbronchial needle engineered for seamless compatibility with both conventional bronchoscopy and EBUS-guided procedures. The BioStar TBNA Needle supports smooth integration into existing EBUS workflows, offering clinicians flexibility across traditional TBNA and EBUS-TBNA techniques while enhancing tissue acquisition reliability for accurate diagnosis of thoracic diseases.

Key Players

Leading Companies of the Market

• Veran Medical Technologies

• Pentax Medical

• Fuji Systems Corp

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

• Ambu A/S

• Getinge AB

• KARL STORZ SE & Co. KG

• Merit Medical Systems Inc.

• PENTAX Medical

• Invivo Corporation

Competitive strategies leveraged by these companies include aggressive investments in R&D for enhanced imaging and biopsy technology, exemplified by Olympus Corporation’s introduction of the latest linear probe EBUS system in 2026, gaining a 7% increase in market presence in Europe. Siemens Healthineers recently secured strategic alliances with healthcare providers to expand clinical access in Asia Pacific, boosting regional market penetration by 12% during 2026.

Endobronchial Ultrasound Biopsy Market Future Outlook

The future outlook for the EBUS biopsy market is promising, driven by the increasing incidence of lung cancer and the expanded use of precision diagnostics. Technological enhancements will likely include higher-resolution imaging, elastography to assess tissue stiffness, and integration with artificial intelligence for real-time decision support. Single-operator platforms and improved biopsy needle designs will enhance procedural efficiency and sample quality. Expansion into outpatient and ambulatory surgical centers will broaden access. Combined with molecular diagnostic tools and next-generation sequencing, EBUS biopsy systems will play an integral role in personalized oncology care, further cementing their position in thoracic disease management.

Endobronchial Ultrasound Biopsy Market Historical Analysis

The endobronchial ultrasound biopsy market emerged in the early 2000s with the introduction of EBUS-TBNA (transbronchial needle aspiration) technology, which allowed real-time ultrasound guidance for sampling lung and mediastinal lymph node tissue. Prior to EBUS, invasive surgical techniques such as mediastinoscopy were required for accurate diagnosis and staging, often associated with a higher risk and longer recovery. The advent of EBUS revolutionized pulmonary diagnostics by combining bronchoscopy with high-resolution ultrasound imaging, enabling minimally invasive, accurate, and safe tissue acquisition. Adoption grew rapidly among pulmonologists and oncologists as evidence of diagnostic accuracy and reduced procedure morbidity accumulated. EBUS became standard practice for lung cancer staging, lymphoma assessment, and investigation of thoracic diseases, supported by improvements in endoscopic imaging and needle systems.

Sources

• Primary Research Interviews:

• • Pulmonologists

  • Thoracic Surgeons

  • Diagnostic Imaging Specialists

  • Hospital Administrators

  • Device Manufacturers

• Databases:

• • FDA Device Listings

  • WHO Diagnostics Data

  • OECD Health Technology

• Magazines:

• • Chest Physician

  • Medical Imaging Today

  • Diagnostic Imaging

  • Pulmonary Review

  • MedTech Outlook

• Journals:

• • Chest Journal

  • European Respiratory Journal

  • Lung Cancer Journal

  • Respiratory Medicine

  • Thoracic Oncology Journal

• Newspapers:

• • Reuters Health

  • Financial Times (Healthcare)

  • The New York Times

  • The Guardian

  • Bloomberg Health

• Associations:

• • American College of Chest Physicians

  • European Respiratory Society

  • World Association for Bronchology

  • American Thoracic Society

  • Society of Thoracic Surgeons